Indisulam

Pack Size	Purity	Price	Availability
1 mg	98%	$25	In Stock
5 mg	98%	$69	In Stock
10 mg	98%	$108	In Stock
25 mg	98%	$172	In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Indisulam is a chloroindole, specifically 3-chloro-1H-indole substituted with a [(4-sulfamoylphenyl)sulfonyl]nitrilo group at position 7. It is a carbonic anhydrase inhibitor and a potential anti-cancer agent in clinical development. It functions as an EC 4.2.1.1 inhibitor and an antineoplastic agent. It is classified as a chloroindole, sulfonamide, and organochlorine compound.

CAS No.	165668-41-7
Product Name	Indisulam

Associated Conditions

colorectal adenocarcinoma·breast neoplasm·colorectal cancer·gastric cancer·neoplasm·

* The information provided here is compiled from public sources and is for reference only.

CAS No.	165668-41-7
MDL No.	MFCD00945325
MF	C₁₄H₁₂ClN₃O₄S₂
MW	385.80
InChI Key	SETFNECMODOHTO-UHFFFAOYSA-N

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Documentation

Indisulam

Pricing & Availability

Product Information

Biological Profile

Properties

Associated Conditions

Related Articles

Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer.

Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation.

Array-based structure and gene expression relationship study of antitumor sulfonamides including N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide and N-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide.

An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients.

Documentation